 | • レポートコード：GIR-107A14292 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、インドールアミン2,3ジオキシゲナーゼ1のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。インドールアミン2,3ジオキシゲナーゼ1の種類別市場規模（BMS-986205、Dcellvax、Epacadostat、F-001287、Galanal、その他）、用途別市場規模（脱毛症、子宮頸がん、胃がん、神経膠腫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・インドールアミン2,3ジオキシゲナーゼ1の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：BirchBioMed Inc、Bristol-Myers Squibb Company、Ensemble Therapeutics Corp、F. Hoffmann-La Roche Ltd、Genentech Inc、Globavir Biosciences Inc、Incyte Corp、IO Biotech ApS、Kyowa Hakko Kirin、Netherlands Translational Research Center BV、NewLink Genetics Corp、Pfizer Inc、Redx Pharma Plc、Regen BioPharma Inc ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：BMS-986205、Dcellvax、Epacadostat、F-001287、Galanal、その他 ・用途別分析2016年-2026年：脱毛症、子宮頸がん、胃がん、神経膠腫、その他 ・インドールアミン2,3ジオキシゲナーゼ1の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・インドールアミン2,3ジオキシゲナーゼ1のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・インドールアミン2,3ジオキシゲナーゼ1のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・インドールアミン2,3ジオキシゲナーゼ1の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・インドールアミン2,3ジオキシゲナーゼ1の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Indoleamine 2,3 Dioxygenase 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Indoleamine 2,3 Dioxygenase 1 size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Indoleamine 2,3 Dioxygenase 1 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Indoleamine 2,3 Dioxygenase 1 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
BMS-986205
Dcellvax
Epacadostat
F-001287
Galanal
Others
Market segment by Application can be divided into
Aolpecia
Cervical Cancer
Gastric Cancer
Glioma
Others
The key market players for global Indoleamine 2,3 Dioxygenase 1 market are listed below:
BirchBioMed Inc
Bristol-Myers Squibb Company
Ensemble Therapeutics Corp
F. Hoffmann-La Roche Ltd
Genentech Inc
Globavir Biosciences Inc
Incyte Corp
IO Biotech ApS
Kyowa Hakko Kirin
Netherlands Translational Research Center BV
NewLink Genetics Corp
Pfizer Inc
Redx Pharma Plc
Regen BioPharma Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Indoleamine 2,3 Dioxygenase 1 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Indoleamine 2,3 Dioxygenase 1, with price, sales, revenue and global market share of Indoleamine 2,3 Dioxygenase 1 from 2019 to 2021.
Chapter 3, the Indoleamine 2,3 Dioxygenase 1 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Indoleamine 2,3 Dioxygenase 1 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Indoleamine 2,3 Dioxygenase 1 market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Indoleamine 2,3 Dioxygenase 1 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Indoleamine 2,3 Dioxygenase 1 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 BMS-986205
1.2.3 Dcellvax
1.2.4 Epacadostat
1.2.5 F-001287
1.2.6 Galanal
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Aolpecia
1.3.3 Cervical Cancer
1.3.4 Gastric Cancer
1.3.5 Glioma
1.3.6 Others
1.4 Global Indoleamine 2,3 Dioxygenase 1 Market Size & Forecast
1.4.1 Global Indoleamine 2,3 Dioxygenase 1 Sales in Value (2016-2026))
1.4.2 Global Indoleamine 2,3 Dioxygenase 1 Sales in Volume (2016-2026)
1.4.3 Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Indoleamine 2,3 Dioxygenase 1 Production Capacity Analysis
1.5.1 Global Indoleamine 2,3 Dioxygenase 1 Total Production Capacity (2016-2026)
1.5.2 Global Indoleamine 2,3 Dioxygenase 1 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Indoleamine 2,3 Dioxygenase 1 Market Drivers
1.6.2 Indoleamine 2,3 Dioxygenase 1 Market Restraints
1.6.3 Indoleamine 2,3 Dioxygenase 1 Trends Analysis
2 Manufacturers Profiles
2.1 BirchBioMed Inc
2.1.1 BirchBioMed Inc Details
2.1.2 BirchBioMed Inc Major Business
2.1.3 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product and Services
2.1.4 BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product and Services
2.2.4 Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Ensemble Therapeutics Corp
2.3.1 Ensemble Therapeutics Corp Details
2.3.2 Ensemble Therapeutics Corp Major Business
2.3.3 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product and Services
2.3.4 Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 F. Hoffmann-La Roche Ltd
2.4.1 F. Hoffmann-La Roche Ltd Details
2.4.2 F. Hoffmann-La Roche Ltd Major Business
2.4.3 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product and Services
2.4.4 F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Genentech Inc
2.5.1 Genentech Inc Details
2.5.2 Genentech Inc Major Business
2.5.3 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product and Services
2.5.4 Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Globavir Biosciences Inc
2.6.1 Globavir Biosciences Inc Details
2.6.2 Globavir Biosciences Inc Major Business
2.6.3 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product and Services
2.6.4 Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Incyte Corp
2.7.1 Incyte Corp Details
2.7.2 Incyte Corp Major Business
2.7.3 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product and Services
2.7.4 Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 IO Biotech ApS
2.8.1 IO Biotech ApS Details
2.8.2 IO Biotech ApS Major Business
2.8.3 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product and Services
2.8.4 IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Kyowa Hakko Kirin
2.9.1 Kyowa Hakko Kirin Details
2.9.2 Kyowa Hakko Kirin Major Business
2.9.3 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product and Services
2.9.4 Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Netherlands Translational Research Center BV
2.10.1 Netherlands Translational Research Center BV Details
2.10.2 Netherlands Translational Research Center BV Major Business
2.10.3 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product and Services
2.10.4 Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 NewLink Genetics Corp
2.11.1 NewLink Genetics Corp Details
2.11.2 NewLink Genetics Corp Major Business
2.11.3 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product and Services
2.11.4 NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Pfizer Inc
2.12.1 Pfizer Inc Details
2.12.2 Pfizer Inc Major Business
2.12.3 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product and Services
2.12.4 Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Redx Pharma Plc
2.13.1 Redx Pharma Plc Details
2.13.2 Redx Pharma Plc Major Business
2.13.3 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product and Services
2.13.4 Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Regen BioPharma Inc
2.14.1 Regen BioPharma Inc Details
2.14.2 Regen BioPharma Inc Major Business
2.14.3 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product and Services
2.14.4 Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Indoleamine 2,3 Dioxygenase 1 Sales by Manufacturer
3.1 Global Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Indoleamine 2,3 Dioxygenase 1
3.4 Market Concentration Rate
3.4.1 Top 3 Indoleamine 2,3 Dioxygenase 1 Manufacturer Market Share
3.4.2 Top 6 Indoleamine 2,3 Dioxygenase 1 Manufacturer Market Share
3.5 Global Indoleamine 2,3 Dioxygenase 1 Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Indoleamine 2,3 Dioxygenase 1 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Indoleamine 2,3 Dioxygenase 1 Market Size by Region
4.1.1 Global Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Region (2016-2026)
4.1.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2016-2026)
4.2 North America Indoleamine 2,3 Dioxygenase 1 Revenue (2016-2026)
4.3 Europe Indoleamine 2,3 Dioxygenase 1 Revenue (2016-2026)
4.4 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue (2016-2026)
4.5 South America Indoleamine 2,3 Dioxygenase 1 Revenue (2016-2026)
4.6 Middle East and Africa Indoleamine 2,3 Dioxygenase 1 Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Type (2016-2026)
5.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2016-2026)
5.3 Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Application (2016-2026)
6.2 Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2016-2026)
6.3 Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2026)
7.2 North America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2026)
7.3 North America Indoleamine 2,3 Dioxygenase 1 Market Size by Country
7.3.1 North America Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2016-2026)
7.3.2 North America Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2026)
8.2 Europe Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2026)
8.3 Europe Indoleamine 2,3 Dioxygenase 1 Market Size by Country
8.3.1 Europe Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2016-2026)
8.3.2 Europe Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2026)
9.2 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2026)
9.3 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Market Size by Region
9.3.1 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2026)
10.2 South America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2026)
10.3 South America Indoleamine 2,3 Dioxygenase 1 Market Size by Country
10.3.1 South America Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2016-2026)
10.3.2 South America Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2026)
11.2 Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2026)
11.3 Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Market Size by Country
11.3.1 Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Indoleamine 2,3 Dioxygenase 1 Typical Distributors
12.3 Indoleamine 2,3 Dioxygenase 1 Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type, (USD Million), 2021-2026
Table 2. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application, (USD Million), 2021-2026
Table 3. BirchBioMed Inc Basic Information, Manufacturing Base and Competitors
Table 4. BirchBioMed Inc Major Business
Table 5. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 6. BirchBioMed Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Company Major Business
Table 9. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 10. Bristol-Myers Squibb Company Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Ensemble Therapeutics Corp Basic Information, Manufacturing Base and Competitors
Table 12. Ensemble Therapeutics Corp Major Business
Table 13. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 14. Ensemble Therapeutics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 16. F. Hoffmann-La Roche Ltd Major Business
Table 17. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 18. F. Hoffmann-La Roche Ltd Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Genentech Inc Basic Information, Manufacturing Base and Competitors
Table 20. Genentech Inc Major Business
Table 21. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 22. Genentech Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Globavir Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 24. Globavir Biosciences Inc Major Business
Table 25. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 26. Globavir Biosciences Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Incyte Corp Basic Information, Manufacturing Base and Competitors
Table 28. Incyte Corp Major Business
Table 29. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 30. Incyte Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. IO Biotech ApS Basic Information, Manufacturing Base and Competitors
Table 32. IO Biotech ApS Major Business
Table 33. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 34. IO Biotech ApS Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 36. Kyowa Hakko Kirin Major Business
Table 37. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 38. Kyowa Hakko Kirin Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Netherlands Translational Research Center BV Basic Information, Manufacturing Base and Competitors
Table 40. Netherlands Translational Research Center BV Major Business
Table 41. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 42. Netherlands Translational Research Center BV Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. NewLink Genetics Corp Basic Information, Manufacturing Base and Competitors
Table 44. NewLink Genetics Corp Major Business
Table 45. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 46. NewLink Genetics Corp Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 48. Pfizer Inc Major Business
Table 49. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 50. Pfizer Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Redx Pharma Plc Basic Information, Manufacturing Base and Competitors
Table 52. Redx Pharma Plc Major Business
Table 53. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 54. Redx Pharma Plc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Regen BioPharma Inc Basic Information, Manufacturing Base and Competitors
Table 56. Regen BioPharma Inc Major Business
Table 57. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Product and Services
Table 58. Regen BioPharma Inc Indoleamine 2,3 Dioxygenase 1 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Indoleamine 2,3 Dioxygenase 1 Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 60. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Indoleamine 2,3 Dioxygenase 1, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Indoleamine 2,3 Dioxygenase 1 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 63. Head Office and Indoleamine 2,3 Dioxygenase 1 Production Site of Key Manufacturer
Table 64. Indoleamine 2,3 Dioxygenase 1 New Entrant and Capacity Expansion Plans
Table 65. Indoleamine 2,3 Dioxygenase 1 Mergers & Acquisitions in the Past Five Years
Table 66. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2016-2021e) & (K Pcs)
Table 67. Global Indoleamine 2,3 Dioxygenase 1 Sales by Region (2021-2026) & (K Pcs)
Table 68. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2016-2021e) & (USD Million)
Table 69. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2021-2026) & (USD Million)
Table 70. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 71. Global Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Pcs)
Table 72. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2016-2021e) & (USD Million)
Table 73. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Type (2021-2026) & (USD Million)
Table 74. Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2016-2021e) & (USD/Pcs)
Table 75. Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2021-2026) & (USD/Pcs)
Table 76. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 77. Global Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Pcs)
Table 78. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2016-2021e) & (USD Million)
Table 79. Global Indoleamine 2,3 Dioxygenase 1 Revenue by Application (2021-2026) & (USD Million)
Table 80. Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2016-2021e) & (USD/Pcs)
Table 81. Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2021-2026) & (USD/Pcs)
Table 82. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2016-2021e) & (K Pcs)
Table 83. North America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Pcs)
Table 84. North America Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2016-2021e) & (USD Million)
Table 85. North America Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2021-2026) & (USD Million)
Table 86. North America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 87. North America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Pcs)
Table 88. North America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 89. North America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Pcs)
Table 90. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2016-2021e) & (K Pcs)
Table 91. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Pcs)
Table 92. Europe Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2016-2021e) & (USD Million)
Table 93. Europe Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2021-2026) & (USD Million)
Table 94. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 95. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Pcs)
Table 96. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 97. Europe Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Pcs)
Table 98. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Region (2016-2021e) & (K Pcs)
Table 99. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Region (2021-2026) & (K Pcs)
Table 100. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2016-2021e) & (USD Million)
Table 101. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 103. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 105. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Pcs)
Table 106. South America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2016-2021e) & (K Pcs)
Table 107. South America Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Pcs)
Table 108. South America Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2016-2021e) & (USD Million)
Table 109. South America Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2021-2026) & (USD Million)
Table 110. South America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 111. South America Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Pcs)
Table 112. South America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 113. South America Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Pcs)
Table 114. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2016-2021e) & (K Pcs)
Table 115. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales by Country (2021-2026) & (K Pcs)
Table 116. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2016-2021e) & (USD Million)
Table 117. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Revenue by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales by Type (2016-2021e) & (K Pcs)
Table 119. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales by Type (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales by Application (2016-2021e) & (K Pcs)
Table 121. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales by Application (2021-2026) & (K Pcs)
Table 122. Direct Channel Pros & Cons
Table 123. Indirect Channel Pros & Cons
Table 124. Indoleamine 2,3 Dioxygenase 1 Typical Distributors
Table 125. Indoleamine 2,3 Dioxygenase 1 Typical Customers
List of Figures
Figure 1. Indoleamine 2,3 Dioxygenase 1 Picture
Figure 2. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type in 2020
Figure 3. BMS-986205
Figure 4. Dcellvax
Figure 5. Epacadostat
Figure 6. F-001287
Figure 7. Galanal
Figure 8. Others
Figure 9. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application in 2020
Figure 10. Aolpecia
Figure 11. Cervical Cancer
Figure 12. Gastric Cancer
Figure 13. Glioma
Figure 14. Others
Figure 15. Global Indoleamine 2,3 Dioxygenase 1 Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 16. Global Indoleamine 2,3 Dioxygenase 1 Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. Global Indoleamine 2,3 Dioxygenase 1 Sales (2016-2026) & (K Pcs)
Figure 18. Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2016-2026) & (USD/Pcs)
Figure 19. Global Indoleamine 2,3 Dioxygenase 1 Production Capacity (2016-2026) & (K Pcs)
Figure 20. Global Indoleamine 2,3 Dioxygenase 1 Production Capacity by Geographic Region: 2020 VS 2021
Figure 21. Indoleamine 2,3 Dioxygenase 1 Market Drivers
Figure 22. Indoleamine 2,3 Dioxygenase 1 Market Restraints
Figure 23. Indoleamine 2,3 Dioxygenase 1 Market Trends
Figure 24. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Manufacturer in 2020
Figure 25. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Manufacturer in 2020
Figure 26. Indoleamine 2,3 Dioxygenase 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 27. Top 3 Indoleamine 2,3 Dioxygenase 1 Manufacturer (Revenue) Market Share in 2020
Figure 28. Top 6 Indoleamine 2,3 Dioxygenase 1 Manufacturer (Revenue) Market Share in 2020
Figure 29. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Region (2016-2026)
Figure 30. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region (2016-2026)
Figure 31. North America Indoleamine 2,3 Dioxygenase 1 Revenue (2016-2026) & (USD Million)
Figure 32. Europe Indoleamine 2,3 Dioxygenase 1 Revenue (2016-2026) & (USD Million)
Figure 33. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue (2016-2026) & (USD Million)
Figure 34. South America Indoleamine 2,3 Dioxygenase 1 Revenue (2016-2026) & (USD Million)
Figure 35. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Revenue (2016-2026) & (USD Million)
Figure 36. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2016-2026)
Figure 37. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Type (2016-2026)
Figure 38. Global Indoleamine 2,3 Dioxygenase 1 Price by Type (2016-2026) & (USD/Pcs)
Figure 39. Global Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2016-2026)
Figure 40. Global Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Application (2016-2026)
Figure 41. Global Indoleamine 2,3 Dioxygenase 1 Price by Application (2016-2026) & (USD/Pcs)
Figure 42. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2016-2026)
Figure 43. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2016-2026)
Figure 44. North America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2016-2026)
Figure 45. North America Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Country (2016-2026)
Figure 46. United States Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2016-2026)
Figure 50. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2016-2026)
Figure 51. Europe Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2016-2026)
Figure 52. Europe Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Country (2016-2026)
Figure 53. Germany Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Region (2016-2026)
Figure 62. China Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Korea Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2016-2026)
Figure 69. South America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2016-2026)
Figure 70. South America Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2016-2026)
Figure 71. South America Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Indoleamine 2,3 Dioxygenase 1 Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Egypt Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Saudi Arabia Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. South Africa Indoleamine 2,3 Dioxygenase 1 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
世界のがんバイオセラピー市場 2021：企業別、地域別、種類・用途別 The Cancer Biotherapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …- 世界の前立腺がん市場 2021：企業別、地域別、種類・用途別 The Prostate Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
- 世界の膀胱がん臨床試験市場 2021：企業別、地域別、種類・用途別 The Bladder Cancer Clinical Trials market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の胃がんの検査・治療・予防市場予測（～2024年）：企業別、地域別、種類・用途別 Stomach cancer begins when cancer cells form in the inner lining of your stomach. These cells can grow into a tumor. Also called gastric cancer, the disease usually grows slowly over many years. There may be no symptoms of stomach cancer early on. Later, symptoms include feeling bloated after eating…
- 世界の精密がん画像市場 2021：企業別、地域別、種類・用途別 The Precision Cancer Imaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…